293 related articles for article (PubMed ID: 16651821)
1. Neuroprotection in vascular dementia.
Martínez-Vila E; Murie-Fernández M; Gállego Pérez-Larraya J; Irimia P
Cerebrovasc Dis; 2006; 21 Suppl 2():106-17. PubMed ID: 16651821
[TBL] [Abstract][Full Text] [Related]
2. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
Erkinjuntti T; Román G; Gauthier S
J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
[TBL] [Abstract][Full Text] [Related]
3. Facts, myths, and controversies in vascular dementia.
Román GC
J Neurol Sci; 2004 Nov; 226(1-2):49-52. PubMed ID: 15537519
[TBL] [Abstract][Full Text] [Related]
4. Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
Farlow MR
Mayo Clin Proc; 2006 Oct; 81(10):1350-8. PubMed ID: 17036561
[TBL] [Abstract][Full Text] [Related]
5. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
6. Vascular dementia: distinguishing characteristics, treatment, and prevention.
Román GC
J Am Geriatr Soc; 2003 May; 51(5 Suppl Dementia):S296-304. PubMed ID: 12801386
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
Kavirajan H; Schneider LS
Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
[TBL] [Abstract][Full Text] [Related]
8. Drug therapy of dementia in elderly patients. A review.
Olsen CE; Poulsen HD; Lublin HK
Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies for vascular dementia and vascular cognitive impairment.
Erkinjuntti T; Román G; Gauthier S; Feldman H; Rockwood K
Stroke; 2004 Apr; 35(4):1010-7. PubMed ID: 15001795
[TBL] [Abstract][Full Text] [Related]
10. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
11. Effective pharmacological management of Alzheimer's disease.
Atri A
Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
Rojas-Fernandez CH; Moorhouse P
Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
[TBL] [Abstract][Full Text] [Related]
13. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials.
Román GC; Wilkinson DG; Doody RS; Black SE; Salloway SP; Schindler RJ
Dement Geriatr Cogn Disord; 2005; 20(6):338-44. PubMed ID: 16192723
[TBL] [Abstract][Full Text] [Related]
14. Vascular dementia. Advances in nosology, diagnosis, treatment and prevention.
Román GC
Panminerva Med; 2004 Dec; 46(4):207-15. PubMed ID: 15876977
[TBL] [Abstract][Full Text] [Related]
15. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).
Maelicke A
Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923
[TBL] [Abstract][Full Text] [Related]
16. Treating the full spectrum of dementia with memantine.
Winblad B; Jelic V
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S41-6. PubMed ID: 12973749
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological prevention and treatment of vascular dementia: approaches and perspectives.
Baskys A; Cheng JX
Exp Gerontol; 2012 Nov; 47(11):887-91. PubMed ID: 22796225
[TBL] [Abstract][Full Text] [Related]
18. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
19. Memantine: new preparation. Poor evaluation and uncertain benefit in Alzheimer's disease.
Prescrire Int; 2003 Dec; 12(68):203-5. PubMed ID: 14986682
[TBL] [Abstract][Full Text] [Related]
20. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia.
Paci C; Gobbato R; Carboni T; Sanguigni S; Santone A; Curatola L
Neurol Sci; 2006 Feb; 26(6):435-7. PubMed ID: 16601937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
